Replies to post #124424 on Biotech Values

[DewDiligence]

The results look great, so why is the stock not reacting?

MNTA’s share price is up 2-3% on a day when the broad market is getting hammered, which is pretty good considering that MNTA’s 2Q11 results were already known within a tight band (as explained in the prologue of #msg-65857564).

[DewDiligence]

what has the big short interest so convinced of the opposite view?

What’s notable in this instance is not what the shorts know, but rather what they fail to understand: that Teva’s Lovenox will not gain FDA approval for a very long time, if ever.